Cargando…

High-Throughput Sequencing Analysis of Post-Liver Transplantation HCV E2 Glycoprotein Evolution in the Presence and Absence of Neutralizing Monoclonal Antibody

Chronic hepatitis C virus (HCV) infection is the most common cause of end-stage liver disease, often leading to liver transplantation, in which case circulating virions typically infect the transplanted liver within hours and viral concentrations can quickly exceed pre-transplant levels. MBL-HCV1 is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babcock, Gregory J., Iyer, Sowmya, Smith, Heidi L., Wang, Yang, Rowley, Kirk, Ambrosino, Donna M., Zamore, Phillip D., Pierce, Brian G., Molrine, Deborah C., Weng, Zhiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067308/ https://www.ncbi.nlm.nih.gov/pubmed/24956119 http://dx.doi.org/10.1371/journal.pone.0100325

Ejemplares similares

Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
por: Morin, Trevor J., et al.
Publicado: (2012)

Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
por: Krey, Thomas, et al.
Publicado: (2013)

Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
por: El Abd, Yasmine S, et al.
Publicado: (2011)

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
por: Owsianka, Ania M., et al.
Publicado: (2008)

A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus
por: Du, Ruikun, et al.
Publicado: (2017)

Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
por: Budigi, Yadunanda, et al.
Publicado: (2018)

Identifying immunologically-vulnerable regions of the HCV E2 glycoprotein and broadly neutralizing antibodies that target them
por: Quadeer, Ahmed A., et al.
Publicado: (2019)

Patient-derived monoclonal antibody neutralizes HCV infection in vitro and vivo without generating escape mutants
por: Yokokawa, Hiroshi, et al.
Publicado: (2022)

Strand-specific libraries for high throughput RNA sequencing (RNA-Seq) prepared without poly(A) selection
por: Zhang, Zhao, et al.
Publicado: (2012)

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein
por: Flyak, Andrew I, et al.
Publicado: (2020)

Absence vs. presence
por: Ramkumar, Swaminathane
Publicado: (2014)

Spatial limits of visuotactile interactions in the presence and absence of tactile stimulation
por: Mirams, Laura, et al.
Publicado: (2017)

Potency of a Human Monoclonal Antibody to Diphtheria Toxin Relative to Equine Diphtheria Anti-toxin in an Animal Model
por: Smith, Heidi, et al.
Publicado: (2015)

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
por: Robinson, James E., et al.
Publicado: (2016)

Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody
por: Trirawatanapong, Thaweesak, et al.
Publicado: (1992)

Monoclonal antibodies to bovine coronavirus: Characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins()
por: Deregt, Dirk, et al.
Publicado: (1987)

A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
por: Kuraoka, Masayuki, et al.
Publicado: (2023)

Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV
por: Marín, María Q., et al.
Publicado: (2020)

The Presence of Consciousness in Absence Seizures
por: Bayne, Tim
Publicado: (2011)

A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B
por: Okamoto, Miwa, et al.
Publicado: (2023)

HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development
por: Ströh, Luisa J., et al.
Publicado: (2020)

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins
por: Tripp, Ralph A., et al.
Publicado: (2005)

Mathematical Modelling of HIV-HCV Coinfection Dynamics in Absence of Therapy
por: Mayanja, Edison, et al.
Publicado: (2020)

Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice
por: Gillet, Laurent, et al.
Publicado: (2006)

V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
por: Guo, D, et al.
Publicado: (2012)

Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody
por: Xu, Kai, et al.
Publicado: (2013)

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance
por: Urbanowicz, Richard A., et al.
Publicado: (2016)

Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria anti-toxin in a guinea pig intoxication model
por: Smith, Heidi L., et al.
Publicado: (2016)

Identification of novel neutralizing determinants for protection against HCV
por: Alzua, Garazi P., et al.
Publicado: (2023)

Development of global consensus sequence of HCV glycoproteins involved in viral entry
por: Idrees, Sobia, et al.
Publicado: (2013)

Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs
por: Jourdan, N., et al.
Publicado: (2006)

Influenza virus glycoprotein-reactive human monoclonal antibodies
por: Li, Yanbai, et al.
Publicado: (2020)

HCMV Infection of Human Trophoblast Progenitor Cells of the Placenta Is Neutralized by a Human Monoclonal Antibody to Glycoprotein B and Not by Antibodies to the Pentamer Complex
por: Zydek, Martin, et al.
Publicado: (2014)

Identification of Human Monoclonal Antibodies Specific for Human SOD1 Recognizing Distinct Epitopes and Forms of SOD1
por: Broering, Teresa J., et al.
Publicado: (2013)

Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
por: Keck, Zhen-yong, et al.
Publicado: (2012)

Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases
por: Flego, Michela, et al.
Publicado: (2013)

MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
por: López-Gil, Elena, et al.
Publicado: (2020)

BacMam virus-based surface display for HCV E2 glycoprotein induces strong cross-neutralizing antibodies and cellular immune responses in vaccinated mice
por: Kord, Ebrahim, et al.
Publicado: (2021)

Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein
por: Al Olaby, Reem R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7hpng34ckiaquh65r9ikp476q3